Key facts
- This page summarizes Nicholas Plummer's Form 4 filing for VOLITIONRX LTD (VNRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2023, 16:00.
Nicholas Plummer - 05 Jul 2023 Form 4 Insider Report for VOLITIONRX LTD (VNRX)
- Reporting relationship
- GC - Volition Diagnostics
- Issuer ticker
- VNRX
- Reported as of
- 05 Jul 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Jul 2023, 16:00:15 UTC
- Prior SEC filing
- 13 Jan 2023
- Next SEC filing
- 26 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nicholas Plummer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nicholas Plummer filed Form 4 for VOLITIONRX LTD (VNRX) on 07 Jul 2023.
Change
- Previous filing in this sequence was filed on 13 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VNRX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +23,400
- Change %
- +33%
- Price
- $0.000000
- Shares after
- 94,394
- Date
- 05 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On October 4, 2022, the reporting person was awarded 52,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 23,400 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 7,800 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 9,100 RSUs and 19,500 RSUs subject to the award previously vested and remain subject to time-based vesting.